SOHO State of the Art Updates and Next Questions: Measurable Residual Disease in Acute Lymphoblastic Leukemia - Optimization and Innovation in 2022 and Beyond
- Resource Type
- Review Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia December 2022 22(12):878-882 - Subject
- Language
- ISSN
- 2152-2650